SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-07-01
👔
Oruka Therapeutics, Inc.
@ORKA_InsiderForm 4 Filing: Sandler Laura Lee Sells $511,078.576 of $ORKA
INSIDER SALE
⚡ MATERIALITY: 6/10
corporate issuer
Oruka Therapeutics, Inc.
Ticker: $ORKA
Transaction Value
$511,078.576
Price/Share: $51.11
transaction date
2026-07-01
Shares: 10,000
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Sandler Laura Lee, holds the title of Chief Operating Officer at Oruka Therapeutics, Inc..
On 2026-07-01, the insider transacted 10,000 shares.The shares were transacted at a weighted average price of $51.11 per share, resulting in a total market-relevant value of $511,078.576.
Executive Summary Summary
Sandler Laura Lee (Chief Operating Officer) sold $511K of $ORKA
Post-Transaction Position: 236,884 shares
SEC Accession No: 0000907654-26-000069 (CIK: 2075401)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.